Merrimack Pharmaceuticals Inc

General ticker "MACK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $189.8M

Merrimack Pharmaceuticals Inc follows the US Stock Market performance with the rate: 50.4%.

Estimated limits based on current volatility of 0.1%: low 15.13$, high 15.17$

Factors to consider:

  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 predicted range: [8.88$, 18.63$]
  • 2024-12-30 to 2025-12-30 predicted range: [8.73$, 18.10$]

Financial Metrics affecting the MACK estimates:

  • Negative: Non-GAAP EPS of -0.08 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: Operating Cash Flow per share of -0.11 <= 0.20
  • Negative: negative Net Income
  • Negative: Industry Operating Cash Flow per share (median) of -1.49 <= 0.29
  • Negative: Industry Earnings per Price (median) of -0.28 <= 0.01

Similar symbols

Short-term MACK quotes

Long-term MACK plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $2.47MM $1.73MM $2.18MM
Operating Income $-2.47MM $-1.73MM $-2.18MM
Non-Operating Income $0.02MM $0.19MM $1.01MM
Income(Loss) $-2.45MM $-1.54MM $-1.17MM
Taxes $0.00MM $0.00MM $0.01MM
Profit(Loss) $-2.46MM $-1.54MM $-1.18MM
Stockholders Equity $14.19MM $19.25MM $18.75MM
Assets $14.75MM $19.84MM $19.19MM
Operating Cash Flow $-0.22MM $-1.74MM $-1.52MM
Investing Cash Flow $0.14MM $0.45MM $-12.45MM
Financing Cash Flow $0.24MM $6.53MM $0.52MM
Earnings Per Share* $-0.18 $-0.11 $-0.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.